Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies
Abstract Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment paradigms for hematological malignancies. However, more than half of these patients cannot achieve sustainable tumor control, partially due to the inadequate potency of CAR-T cells in eradicating tumor cells. T...
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Nature Publishing Group
2024-12-01
|
| Serija: | Blood Cancer Journal |
| Online pristup: | https://doi.org/10.1038/s41408-024-01193-6 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|